Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
MYRIAD GENETICS INC
Report date March 22, 2024 · Filed March 25, 2024
Section 16 reporting ended · disclosed 2024-03-25. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 65,002 |
Reported balance
After 2024-03-22 transaction · row 1
1 source rowRow 1 · 2024-03-22 · Tax withholding · Disposed 1,441 · Balance 65,002 F1: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 22, 2024 Filed Mar 25, 2024 20:32 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Tax withholdingCommon Stock | 1,441 | $22.24 | $32,047.84 |
DisclosureSEC source: 0001628280-24-012920 · wk-form4_1711398729.xml · nonDerivative · entry 1 Wong Pamela · CIK 0001885862 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,002 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 20:46 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Tax withholdingCommon Stock | 2,568 | $21.16 | $54,338.88 |
DisclosureSEC source: 0001628280-24-011688 · wk-form4_1710794786.xml · nonDerivative · entry 1 Wong Pamela · CIK 0001885862 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,443 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 15, 2024. Read SEC document |
| October 18, 2023 Filed Oct 19, 2023 20:17 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Tax withholdingCommon Stock | 1,967 | $15.06 | $29,623.02 |
DisclosureSEC source: 0001885862-23-000003 · wk-form4_1697746660.xml · nonDerivative · entry 2 Wong Pamela · CIK 0001885862 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,011 F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 18, 2023. Read SEC document |
| October 18, 2023 Filed Oct 19, 2023 20:17 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Tax withholdingCommon Stock | 1,342 | $15.06 | $20,210.52 |
DisclosureSEC source: 0001885862-23-000003 · wk-form4_1697746660.xml · nonDerivative · entry 1 Wong Pamela · CIK 0001885862 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,978 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 18, 2023. Read SEC document |
| March 22, 2023 Filed Mar 23, 2023 20:29 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Tax withholdingCommon Stock | 1,432 | $22.91 | $32,807.12 |
DisclosureSEC source: 0001628280-23-009051 · wf-form4_167960334155262.xml · nonDerivative · entry 1 Wong Pamela · CIK 0001885862 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,320 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2023. Read SEC document |
| March 15, 2023 Filed Mar 16, 2023 20:32 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 21,892 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-008324 · wf-form4_167899871320123.xml · nonDerivative · entry 1 Wong Pamela · CIK 0001885862 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,752 F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 20:12 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Tax withholdingCommon Stock | 1,972 | $20.00 | $39,440.00 |
DisclosureSEC source: 0001885862-22-000005 · wf-form4_166621032747004.xml · nonDerivative · entry 2 Wong Pamela · CIK 0001885862 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,860 F2 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 18, 2022. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 20:12 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | Tax withholdingCommon Stock | 1,346 | $20.00 | $26,920.00 |
DisclosureSEC source: 0001885862-22-000005 · wf-form4_166621032747004.xml · nonDerivative · entry 1 Wong Pamela · CIK 0001885862 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,832 F1 · kind: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 18, 2022. Read SEC document |
| March 22, 2022 Filed Mar 23, 2022 21:05 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 16,353 | $0.00 | $0.00 |
DisclosureSEC source: 0001885862-22-000004 · edgardoc.xml · nonDerivative · entry 1 Wong Pamela · CIK 0001885862 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,178 F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 16, 2022 Filed Feb 18, 2022 22:26 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 23,072 | $0.00 | $0.00 |
DisclosureSEC source: 0001885862-22-000002 · edgardoc.xml · nonDerivative · entry 1 Wong Pamela · CIK 0001885862 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,825 F1 · kind: Consists of performance-based restricted stock units (PSUs) granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. The PSUs were initially granted on October 18, 2021, subject to accomplishment of pre-determined performance metrics. On February 16, 2022, the Compensation and Human Capital Committee determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock, and vests 25% on October 18, 2022, 25% on October 18, 2023, 25% on October 18, 2024, and 25% on October 18, 2025. Read SEC document |
| October 18, 2021 Filed Oct 18, 2021 23:16 UTC | MYRIAD GENETICS INC MYGN · Entity 5953 | GrantCommon Stock | 15,753 | $0.00 | $0.00 |
DisclosureSEC source: 0001885862-21-000004 · edgardoc.xml · nonDerivative · entry 1 Wong Pamela · CIK 0001885862 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,753 F1 · kind: Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.